We are live on ! Find out more
NVNO icon

enVVeno Medical

3 hedge funds and large institutions have $173K invested in enVVeno Medical in 2018 Q3 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more funds holding

Funds holding: 2 → 3 (+1)

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

0.11% more ownership

Funds ownership: 0.44% → 0.55% (+0.11%)

11% less capital inflows, than outflows

Capital inflows: $169K | Capital outflows: $190K

Holders
3
Holders Change
+1
Holders Change %
+50%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

NVNO Hedge Fund Activity: Q3 2018 in Review

3 of the 4,393 institutional investors tracked by Wall St. Rank reported a position in enVVeno Medical (NVNO) for Q3 2018, worth a combined $173K — down 8.9% from $190K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new NVNO positions and 2 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Vanguard Group, opening a new position worth an estimated $139K. The largest seller was Goldman Sachs, exiting entirely with an estimated $127K sold.

  • 3 institutional investors held enVVeno Medical (NVNO) as of Q3 2018, up from 2 in Q2 2018.
  • Funds reported $173K of enVVeno Medical stock for Q3 2018, down 8.9% quarter-over-quarter.
  • 3 funds opened new enVVeno Medical positions in Q3 2018 and 2 closed out, a net change of +1 holder.
  • The largest enVVeno Medical buyer in Q3 2018 was Vanguard Group, an estimated $139K added.
  • The largest enVVeno Medical seller in Q3 2018 was Goldman Sachs, an estimated $127K sold.

Based on aggregated 13F filings for Q3 2018.